US 12077593
Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies
granted A61KA61K2039/505A61K31/485
Quick answer
US patent 12077593 (Stabilized formulations containing anti-interleukin-6 receptor (IL-6R) antibodies) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61K, A61K2039/505, A61K31/485, A61K39/3955, A61K47/183